{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:24:24Z","timestamp":1793741064376,"version":"4.6.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006004","name":"Tohoku University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006004","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19H05649"],"award-info":[{"award-number":["19H05649"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.redox.2025.103819","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T23:27:00Z","timestamp":1754954820000},"page":"103819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Cisplatin-induced genetic alterations in KEAP1 promote therapeutic resistance in head and neck squamous cell carcinoma"],"prefix":"10.1016","volume":"86","author":[{"given":"Yuki","family":"Nakayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Wakamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Uruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Otsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ohkoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Shirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Katori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9073-9436","authenticated-orcid":false,"given":"Masayuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.redox.2025.103819_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ijc.23033","article-title":"Tobacco smoking and cancer: a meta-analysis","volume":"122","author":"Gandini","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.redox.2025.103819_bib2","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S1470-2045(08)70173-6","article-title":"Smokeless tobacco and cancer","volume":"9","author":"Boffetta","year":"2008","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.redox.2025.103819_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra1715715","article-title":"Head and neck cancer","volume":"382","author":"Chow","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.redox.2025.103819_bib4","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1053\/j.seminoncol.2004.09.006","article-title":"Concurrent chemoradiotherapy for head and neck cancer","volume":"31","author":"Brockstein","year":"2004","journal-title":"Semin. Oncol."},{"issue":"3","key":"10.1016\/j.redox.2025.103819_bib5","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","article-title":"The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis","volume":"98","author":"Yamamoto","year":"2018","journal-title":"Physiol. Rev."},{"issue":"13","key":"10.1016\/j.redox.2025.103819_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00099-20","article-title":"The molecular mechanisms regulating the KEAP1-NRF2 pathway","volume":"40","author":"Baird","year":"2020","journal-title":"Mol. Cell Biol."},{"issue":"16","key":"10.1016\/j.redox.2025.103819_bib7","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/MCB.24.16.7130-7139.2004","article-title":"Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2","volume":"24","author":"Kobayashi","year":"2004","journal-title":"Mol. Cell Biol."},{"issue":"20","key":"10.1016\/j.redox.2025.103819_bib8","doi-asserted-by":"crossref","first-page":"10228","DOI":"10.1093\/nar\/gks827","article-title":"Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks","volume":"40","author":"Hirotsu","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.redox.2025.103819_bib9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","article-title":"An Nrf2\/small maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements","volume":"236","author":"Itoh","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.redox.2025.103819_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11624","article-title":"Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription","volume":"7","author":"Kobayashi","year":"2016","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.redox.2025.103819_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1158\/1940-6207.CAPR-12-0401-T","article-title":"Roles of Keap1-Nrf2 system in upper aerodigestive tract carcinogenesis","volume":"6","author":"Ohkoshi","year":"2013","journal-title":"Cancer Prev. Res."},{"issue":"4","key":"10.1016\/j.redox.2025.103819_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114104","article-title":"Differential squamous cell fates elicited by NRF2 gain of function versus KEAP1 loss of function","volume":"43","author":"Takahashi","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.redox.2025.103819_bib13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.freeradbiomed.2022.06.239","article-title":"Nrf2 protects against radiation-induced oral mucositis via antioxidation and keratin layer thickening","volume":"188","author":"Wakamori","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2025.103819_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fonc.2017.00085","article-title":"The KEAP1-NRF2 system in cancer","volume":"7","author":"Taguchi","year":"2017","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.redox.2025.103819_bib15","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1111\/cas.16355","article-title":"Specific cancer types and prognosis in patients with variations in the KEAP1-NRF2 system: a retrospective cohort study","volume":"115","author":"Iwasaki","year":"2024","journal-title":"Cancer Sci."},{"issue":"10","key":"10.1016\/j.redox.2025.103819_bib16","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41422-020-0333-6","article-title":"Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma","volume":"30","author":"Cui","year":"2020","journal-title":"Cell Res."},{"issue":"6","key":"10.1016\/j.redox.2025.103819_bib17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.3564","article-title":"Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas","volume":"48","author":"Campbell","year":"2016","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.redox.2025.103819_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jtho.2021.10.013","article-title":"Diminished efficacy of programmed Death-(Ligand)1 inhibition in STK11- and KEAP1-Mutant lung adenocarcinoma is affected by KRAS mutation status","volume":"17","author":"Ricciuti","year":"2022","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.redox.2025.103819_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12885-017-3907-z","article-title":"Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer","volume":"18","author":"Namani","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.redox.2025.103819_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102925","article-title":"Cisplatin: the first metal based anticancer drug","volume":"88","author":"Ghosh","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"8","key":"10.1016\/j.redox.2025.103819_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135083","article-title":"Mechanism of cisplatin-induced cytotoxicity is correlated to impaired metabolism due to mitochondrial ROS generation","volume":"10","author":"Choi","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.redox.2025.103819_bib22","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41419-019-2081-4","article-title":"Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells","volume":"10","author":"Kleih","year":"2019","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.redox.2025.103819_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081162","article-title":"Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions","volume":"8","author":"Marullo","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.redox.2025.103819_bib24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4143\/crt.2016.572","article-title":"Ferroptosis: a novel anti-tumor action for cisplatin","volume":"50","author":"Guo","year":"2018","journal-title":"Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.redox.2025.103819_bib25","doi-asserted-by":"crossref","DOI":"10.3892\/or.2023.8561","article-title":"Expression of Ferredoxin1 in cisplatin-resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin","volume":"49","author":"Takahashi","year":"2023","journal-title":"Oncol. Rep."},{"issue":"15","key":"10.1016\/j.redox.2025.103819_bib26","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.redox.2025.103819_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/430939","article-title":"Role of glutathione in the regulation of cisplatin resistance in cancer chemotherapy","volume":"2010","author":"Chen","year":"2010","journal-title":"Met Based Drugs"},{"issue":"24","key":"10.1016\/j.redox.2025.103819_bib28","first-page":"5475","article-title":"A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells","volume":"57","author":"Koike","year":"1997","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.redox.2025.103819_bib29","first-page":"965","article-title":"Multidrug resistance-associated protein 2 determines the efficacy of cisplatin in patients with hepatocellular carcinoma","volume":"23","author":"Korita","year":"2010","journal-title":"Oncol. Rep."},{"issue":"7","key":"10.1016\/j.redox.2025.103819_bib30","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/carcin\/9.7.1283","article-title":"Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effects","volume":"9","author":"Lewis","year":"1988","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.redox.2025.103819_bib31","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.bjc.6606071","article-title":"Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma","volume":"104","author":"Yamasaki","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.redox.2025.103819_bib32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.canlet.2021.07.037","article-title":"The developmental origin of cancers defines basic principles of cisplatin resistance","volume":"519","author":"Skowron","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.redox.2025.103819_bib33","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-22-2747","article-title":"Dysregulation and epigenetic reprogramming of NRF2 signaling axis promote acquisition of cisplatin resistance and metastasis in head and neck squamous cell carcinoma","author":"Osman","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.redox.2025.103819_bib34","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1038\/s41416-023-02253-7","article-title":"Evolution of cisplatin resistance through coordinated metabolic reprogramming of the cellular reductive state","volume":"128","author":"Yu","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.redox.2025.103819_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00473-20","article-title":"NRF2-Dependent bioactivation of mitomycin C as a novel strategy to target KEAP1-NRF2 pathway activation in human cancer","volume":"41","author":"Baird","year":"2021","journal-title":"Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.redox.2025.103819_bib36","first-page":"141","article-title":"Mitomycin, a new antibiotic from streptomyces. I","volume":"9","author":"Hata","year":"1956","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"4","key":"10.1016\/j.redox.2025.103819_bib37","first-page":"405","article-title":"Enzymology of mitomycin C metabolic activation in tumour tissue: implications for enzyme-directed bioreductive drug development","volume":"56","author":"Cummings","year":"1998","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.redox.2025.103819_bib38","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s00405-010-1257-4","article-title":"Upregulation of IGF2 is associated with an acquired resistance for cis-diamminedichloroplatinum in human head and neck squamous cell carcinoma","volume":"267","author":"Ogawa","year":"2010","journal-title":"Eur. Arch. Otorhinolaryngol."},{"issue":"6","key":"10.1016\/j.redox.2025.103819_bib39","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1074\/jbc.M411451200","article-title":"Nrf2 transcriptionally activates the mafG gene through an antioxidant response element","volume":"280","author":"Katsuoka","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"7269","key":"10.1016\/j.redox.2025.103819_bib40","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature08460","article-title":"Systematic RNA interference reveals that oncogenic KRAS-Driven cancers require TBK1","volume":"462","author":"Barbie","year":"2009","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.redox.2025.103819_bib41","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1245\/s10434-014-3600-2","article-title":"Nrf2 is useful for predicting the effect of chemoradiation therapy on esophageal squamous cell carcinoma","volume":"21","author":"Kawasaki","year":"2014","journal-title":"Ann. Surg Oncol."},{"issue":"8","key":"10.1016\/j.redox.2025.103819_bib42","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data","volume":"44","author":"Colaprico","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.redox.2025.103819_bib43","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/bioinformatics\/btz631","article-title":"G3viz: an R package to interactively visualize genetic mutation data using a lollipop-diagram","volume":"36","author":"Guo","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.redox.2025.103819_bib44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13059-016-0893-4","article-title":"DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution","volume":"17","author":"Rosenthal","year":"2016","journal-title":"Genome Biol."},{"issue":"7793","key":"10.1016\/j.redox.2025.103819_bib45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.redox.2025.103819_bib46","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1101\/gr.230219.117","article-title":"In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors","volume":"28","author":"Boot","year":"2018","journal-title":"Genome Res."},{"issue":"9","key":"10.1016\/j.redox.2025.103819_bib47","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1593\/neo.11750","article-title":"NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer","volume":"13","author":"Shibata","year":"2011","journal-title":"Neoplasia"},{"issue":"6","key":"10.1016\/j.redox.2025.103819_bib48","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tips.2013.04.005","article-title":"Toward clinical application of the Keap1-Nrf2 pathway","volume":"34","author":"Suzuki","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.redox.2025.103819_bib49","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2443.2003.00640.x","article-title":"Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles","volume":"8","author":"Itoh","year":"2003","journal-title":"Genes Cells"},{"issue":"1","key":"10.1016\/j.redox.2025.103819_bib50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/ctrv.2000.0202","article-title":"A clinical update","volume":"27","author":"Bradner","year":"2001","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.redox.2025.103819_bib51","first-page":"1","article-title":"Anticancer effect of C19-Position substituted geldanamycin derivatives targeting NRF2-NQO1-activated esophageal squamous cell carcinoma","author":"Oshikiri","year":"2024","journal-title":"Mol. Cell Biol."},{"issue":"7536","key":"10.1016\/j.redox.2025.103819_bib52","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","author":"Cancer Genome Atlas","year":"2015","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.redox.2025.103819_bib53","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1158\/2159-8290.CD-23-0902","article-title":"Pan-cancer comparative and integrative analyses of driver alterations using Japanese and international genomic databases","volume":"14","author":"Horie","year":"2024","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.redox.2025.103819_bib54","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2443.2010.01473.x","article-title":"Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution","volume":"16","author":"Taguchi","year":"2011","journal-title":"Genes Cells"},{"issue":"1","key":"10.1016\/j.redox.2025.103819_bib55","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2012.05.016","article-title":"Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming","volume":"22","author":"Mitsuishi","year":"2012","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.redox.2025.103819_bib56","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ng.155","article-title":"NAD(P)H:quinone oxidoreductase 1 NQO1\u22172 genotype (P187S) is a strong prognostic and predictive factor in breast cancer","volume":"40","author":"Fagerholm","year":"2008","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.redox.2025.103819_bib57","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/bjc.2013.357","article-title":"The NQO1 polymorphism C609T (Pro187Ser) and cancer susceptibility: a comprehensive meta-analysis","volume":"109","author":"Lajin","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.redox.2025.103819_bib58","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0026-895X(24)12836-2","article-title":"Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1","volume":"59","author":"Siegel","year":"2001","journal-title":"Mol. Pharmacol."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725003325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725003325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:57:55Z","timestamp":1772899075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231725003325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":58,"alternative-id":["S2213231725003325"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2025.103819","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cisplatin-induced genetic alterations in KEAP1 promote therapeutic resistance in head and neck squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2025.103819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103819"}}